cGMP-Aligned · FDA-Registered U.S. Facility · Third-Party COA on Every LotSupplied for Research Use Only
BioRegenEx · Research

How Clinics Choose an MSC Exosome Supplier: COA, Sourcing & Cold Chain

← Back to Research Library

If you run a regenerative, aesthetic, or longevity practice, your exosome supply is only as good as the documentation behind it. The market is crowded, and product quality varies widely from one source to the next. This guide covers what to verify before you place an order — the same standards a careful buyer should hold every supplier to.

1. Source and characterization

Start with where the exosomes come from. Mesenchymal stem cell (MSC) exosomes can be derived from different tissue sources; Wharton’s Jelly from screened umbilical cord donations is among the most commonly referenced. Ask any supplier to state the source clearly and provide characterization data — particle concentration and size distribution — so you know what you are actually receiving per vial.

Questions to ask:

  • What is the tissue source, and how are donors screened?
  • What is the particle count per dose, and how is it measured?
  • Can you provide characterization data for the specific lot I am buying?

2. The Certificate of Analysis (COA)

A per-lot Certificate of Analysis is the single most important document in this category. It should accompany every order, not be available only on request. A meaningful COA documents sterility and endotoxin testing and ties the results to the exact lot you received. If a supplier cannot produce a lot-specific COA, treat that as a red flag.

3. Manufacturing standards

Ask where and how the product is manufactured. Current Good Manufacturing Practice (cGMP) standards and an FDA-registered facility indicate a level of process discipline and traceability that ad-hoc producers cannot match. Manufacturing standards are about consistency — that one lot performs like the last.

4. Cold chain and handling

Biologics are fragile. A great product mishandled in transit is no longer a great product. Confirm the supplier ships with managed cold-chain logistics and provides clear storage and handling instructions on arrival. Ask what happens if a shipment is delayed or arrives warm.

5. Traceability and support

You want a supplier who can trace a product from source through shipment, and who answers the phone when you have a question. Lot- and batch-level traceability protects your practice and your patients, and dedicated practitioner support is the difference between a vendor and a partner.

A simple supplier checklist

Before you order, confirm the supplier can provide:

  • Clear tissue source and donor screening protocol
  • Particle characterization (count and size)
  • Per-lot Certificate of Analysis (sterility and endotoxin)
  • cGMP manufacturing in an FDA-registered facility
  • Managed cold-chain shipping with handling instructions
  • Lot and batch traceability with responsive support

Frequently asked questions

What should a Certificate of Analysis include?

At minimum, lot-specific sterility and endotoxin testing results, tied to the lot you received.

Why does the tissue source matter?

The source affects consistency and characterization. A supplier should state it plainly and back it with data.

How important is cold chain for exosomes?

Critical. Improper temperature handling in transit can compromise the product before it reaches your practice.

About BioRegenEx: BioRegenEx is a physician-led supplier of MSC-derived exosomes for licensed practitioners, manufactured to cGMP standards in an FDA-registered U.S. facility, with per-lot documentation and managed cold-chain fulfillment. Request a sample.

Important Information

These statements have not been evaluated by the U.S. Food and Drug Administration. BioRegenEx products are not intended to diagnose, treat, cure, or prevent any disease.

Exosome therapy is an emerging regenerative approach. It is investigational, outcomes vary, and individual results cannot be guaranteed. Patient testimonials reflect individual experiences and are not representative of typical results.

References to regulatory standards — including Section 351(a) of the Public Health Service Act — describe the company’s stated quality and compliance approach and should not be interpreted as FDA approval or endorsement of any product.

This presentation is provided for educational and informational purposes only and does not constitute medical advice. Treatment decisions should always be made in consultation with a qualified, licensed healthcare provider.